Wave Life Sciences Ltd. Stock

$5.13

1.91% day before yesterday

Nasdaq, Sep 06, 10:00 pm CET

ISIN

SG9999014716

Symbol

WVE

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Wave Life Sciences Ltd. Stock price

$5.13

-15.70 75.37% 5Y

Nasdaq, Closing price Fri, Sep 06 2024

-0.10 1.91%

ISIN

SG9999014716

Symbol

WVE

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Key metrics

Market capitalization	$639.91m
Enterprise Value	$522.70m
P/E (TTM) P/E ratio	negative
EV/FCF (TTM) EV/FCF	negative
EV/Sales (TTM) EV/Sales	4.73
P/S ratio (TTM) P/S ratio	5.79
P/B ratio (TTM) P/B ratio	negative
Revenue growth (TTM) Revenue growth	202.25%
Revenue (TTM) Revenue	$110.50m
EBIT (operating result TTM) EBIT	$-83.69m
Free Cash Flow (TTM) Free Cash Flow	$-129.10m
Cash position	$153.96m
EPS (TTM) EPS	$-0.58
P/E forward	negative
P/S forward	9.28
EV/Sales forward	7.58
Short interest	5.51%

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Get Started for Free Today

Wave Life Sciences Ltd. Stock Analysis

Unlock Scores for Free

??

8 Analysts have issued a Wave Life Sciences Ltd. forecast:

7x Buy

88%

More details on Analyst Estimates Including Price Targets

8 Analysts have issued a Wave Life Sciences Ltd. forecast:

Buy

88%

Hold

13%

Analyst Estimates with Stock Price Targets

Financial data from Wave Life Sciences Ltd.

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Jun '24		+/- %
Revenue	111 111	202% 202% 100%
- Direct Costs	8.80 8.80	11% 11% 8%
Gross Profit	102 102	281% 281% 92%
- Selling and Administrative Expenses	37 37	23% 23% 34%
- Research and Development Expense	140 140	14% 14% 126%
EBITDA	-75 -75	41% 41% -68%
- Depreciation and Amortization	8.80 8.80	11% 11% 8%
EBIT (Operating Income) EBIT	-84 -84	39% 39% -76%
Net Profit	-74 -74	44% 44% -67%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Wave Life Sciences Ltd. Stock News

Neutral

Seeking Alpha

●

28 days ago

Wave Life Sciences Ltd. (WVE) Q2 2024 Earnings Call Transcript

Wave Life Sciences Ltd. (NASDAQ:WVE ) Q2 2024 Results Conference Call August 8, 2024 8:30 AM ET Company Participants Kate Rausch - Vice President, Investor Relations & Corporate Affairs Paul Bolno - President & Chief Executive Officer Anne-Marie Li-Kwai-Cheung - Chief Development Officer Kyle Moran - Chief Financial Officer Erik Ingelsson - Chief Scientific Officer Conference Call Participants ...

Neutral

GlobeNewsWire

●

about one month ago

Wave Life Sciences Reports Second Quarter 2024 Financial Results and Provides Business Update

Successful clinical translation of Wave's RNA medicines platform in HD patients with WVE-003 provides further validation of Wave's proprietary platform with PN and stereochemistry; opt-in package for WVE-003 submitted to partner Takeda and engagement with regulators initiated to discuss potential path to accelerated approval

Neutral

GlobeNewsWire

●

about one month ago

Wave Life Sciences Second Quarter 2024 Financial Results Scheduled for August 8, 2024

CAMBRIDGE, Mass., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, will host a live webcast and conference call at 8:30 a.m. ET on Thursday, August 8, 2024, to review the company's second quarter 2024 financial results and provide business updates.

More Wave Life Sciences Ltd. News

Company Profile

Wave Life Sciences Ltd. is a biotechnology company, which engages in the development of proprietary synthetic chemistry drug. It focuses on the design, development, and commercialization of nucleic acid-based therapeutics. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Head office	Singapore
CEO	Paul Bolno
Employees	268
Founded	2012
Website	www.wavelifesciences.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now